Vertex and CRISPR Therapeutics have won the backing of NICE for their gene-editing therapy Casgevy as a treatment for the blood disorder beta thalassaemia, a few months after turning it down for ...

Notifications You must be signed in to change notification settings ...

The face can change with Parkinson's disease, and facial masking (also called masked facies, or hypomimia) occurs in roughly half to 70% of all people diagnosed with the neurodegenerative condition.